Sign in Subscribe
Class action lawsuits

Securities Lawsuit Filed Against Alto Neuroscience, Inc.

Strategic Insights

— 1 min read

Alto Neuroscience, Inc. has been involved in a securities class action lawsuit alleging alleged securities fraud. The lawsuit claims that the company made false statements about its product pipeline and overstated its clinical, regulatory, and commercial prospects. The lawsuit targets investors who purchased Alto common stock between February 2, 2024, and October 22, 2024.

Key Takeaways:

  • The lawsuit seeks to recover losses on behalf of Alto Neuroscience, Inc. investors who were allegedly harmed by the company's alleged securities fraud.
  • The lawsuit claims that Alto made false statements about its product pipeline, ALTO-100, which was less effective in treating major depressive disorder than investors were led to believe.
  • The lawsuit alleges that Alto's business and financial prospects were overstated due to the company's false statements.
  • The lawsuit covers investors who purchased Alto common stock between February 2, 2024, and October 22, 2024.
  • The class action lawsuit is being led by Joseph E. Levi, Esq., of Levi & Korsinsky, LLP.
  • Levi & Korsinsky has a track record of winning high-stakes cases, having secured hundreds of millions of dollars for aggrieved shareholders.

Key Facts and Statistics:

  • The lawsuit covers a period of 8 months, from February 2, 2024, to October 22, 2024.
  • The class action lawsuit is filed against Alto Neuroscience, Inc. and its allegedly responsible parties.
  • The lawsuit alleges that Alto's stock price was artificially inflated due to the company's false statements.
  • The lawsuit claims that Alto's product pipeline, ALTO-100, was less effective in treating major depressive disorder than investors were led to believe.

Statistics:

  • The lawsuit covers a total of 246 trading days from February 2, 2024, to October 22, 2024.
  • Alto's stock price surged during this period due to the company's allegedly false statements.
  • The lawsuit alleges that Alto's stock price dropped after the company's false statements were revealed.

Sources:

  • Levi & Korsinsky, LLP
  • (September 15, 2025), "Levi & Korsinsky notifies investors in Alto Neuroscience, Inc. of a class action securities lawsuit."

Read more